The present study proposed that CD3+CD56+ NKT-like cells in PBMCs preactivated by IL-12/15/18 could gain trained immunity with enhanced effector functions, a memory-like phenomenon, analyzing the possible response of these prestimulated cells to K562 tumor cells. This evidence concerns the gene NCAM1 and neoplasm.